NMN shows potential for improving insulin sensitivity by enhancing glucose metabolism, based on preclinical studies. Human studies are needed to confirm these effects and determine safe and effective dosages.
NMN (Nicotinamide Mononucleotide) appears to improve insulin sensitivity by enhancing glucose metabolism. In preclinical studies, NMN supplementation has shown promise in improving insulin signaling pathways and glucose uptake in cells, potentially leading to better blood sugar control and reduced insulin resistance. The exact mechanisms are still under investigation but involve increased levels of NAD+, a crucial coenzyme for cellular energy production and metabolic processes. Improved insulin sensitivity can lead to better glucose utilization by cells and reduced risk of developing type 2 diabetes.